Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 60 M47 M49 M-24 M49 M 121 M Research & development ————— — Operating income 713 M1.56 B1.61 B1.31 B1.14 B 5.62 B Non-Operating Income, Total 336 M337 M460 M468 M466 M 1.73 B Interest expense, net of interest capitalized 35 M38 M37 M38 M37 M 150 M Non-Operating Income, excl. Interest Expenses 301 M299 M423 M430 M429 M 1.58 B Unusual income/expense ————— — Pretax income 2.02 B2.96 B2.92 B2.61 B2.5 B 10.99 B Equity in earnings 53 M162 M134 M155 M160 M 611 M Taxes 121 M214 M215 M210 M98 M 737 M Non-controlling/minority interest ———-1 M— — After tax other income/expense ————— — Net income before discontinued operations 574 M1.24 B1.35 B1.24 B1.05 B 4.87 B Discontinued operations ————— — Net income 574 M1.24 B1.35 B1.24 B1.05 B 4.87 B Dilution adjustment 00000 0 Preferred dividends 10 M10 M10 M10 M10 M 40 M Diluted net income available to common stockholders 564 M1.23 B1.34 B1.23 B1.04 B 4.83 B Basic earnings per share (Basic EPS) 1.513.33.633.392.94 13.26 Diluted earnings per share (Diluted EPS) 1.483.233.563.332.88 13 Average basic shares outstanding 372.9 M372.2 M369 M368.4 M353.2 M — Diluted shares outstanding 381.9 M379.9 M376.1 M375.9 M359.7 M — EBITDA 1.53 B2.41 B2.42 B2.27 B1.9 B 9.01 B EBIT 715 M1.54 B1.58 B1.3 B1.14 B 5.57 B Cost of revenue 3.35 B3.13 B2.99 B3.06 B2.82 B 11.99 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 813 M872 M835 M972 M760 M 3.44 B